Switch to:
GuruFocus has detected 7 Warning Signs with Abbott Laboratories $ABT.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
Abbott Laboratories (NYSE:ABT)
Research & Development
$1,590 Mil (TTM As of Mar. 2017)

This is the expense the company spent on research and development. Abbott Laboratories's research and development for the three months ended in Mar. 2017 was $547 Mil. Its research and development for the trailing twelve months (TTM) ended in Mar. 2017 was $1,590 Mil.


Definition

This is the expense the company spent on research and development.

Abbott Laboratories Research & Development for the trailing twelve months (TTM) ended in Mar. 2017 was 348 (Jun. 2016 ) + 352 (Sep. 2016 ) + 343 (Dec. 2016 ) + 547 (Mar. 2017 ) = $1,590 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Related Terms

Gross Profit


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

Abbott Laboratories Annual Data

Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15Dec16
Research & Development 2,5062,6892,9143,7241,5121,4611,3711,3451,4051,422

Abbott Laboratories Quarterly Data

Mar15Jun15Sep15Dec15Mar16Jun16Sep16Dec16Mar17Jun17
Research & Development 313345378369379348352343547513
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK